Literature DB >> 27384554

Retraction: A. Amedei et al. Multiple Sclerosis: The Role of Cytokines in Pathogenesis and in Therapies. Int. J. Mol. Sci. 2012, 13, 13438-13460.

.   

Abstract

We have been made aware that the title paper [1] contains text taken verbatim from previously published articles by Shyi-Jou Chen et al. [2] and Ghislain Opdenakker and Jo Van Damme [3].[...].

Entities:  

Year:  2016        PMID: 27384554      PMCID: PMC4964397          DOI: 10.3390/ijms17071021

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


We have been made aware that the title paper [1] contains text taken verbatim from previously published articles by Shyi-Jou Chen et al. [2] and Ghislain Opdenakker and Jo Van Damme [3]. MDPI is a member of the Committee on Publication Ethics and takes the responsibility to enforce strict ethical policies and standards very seriously. To ensure the addition of only high quality scientific works to the field of scholarly publication, paper [1] is retracted and shall be marked accordingly. We apologize to our readership that this went undetected until now.
  3 in total

Review 1.  Probing cytokines, chemokines and matrix metalloproteinases towards better immunotherapies of multiple sclerosis.

Authors:  Ghislain Opdenakker; Jo Van Damme
Journal:  Cytokine Growth Factor Rev       Date:  2011-11-25       Impact factor: 7.638

Review 2.  Current status of the immunomodulation and immunomediated therapeutic strategies for multiple sclerosis.

Authors:  Shyi-Jou Chen; Yen-Ling Wang; Hueng-Chuen Fan; Wen-Tsung Lo; Chih-Chien Wang; Huey-Kang Sytwu
Journal:  Clin Dev Immunol       Date:  2011-12-06

Review 3.  Multiple sclerosis: the role of cytokines in pathogenesis and in therapies.

Authors:  Amedeo Amedei; Domenico Prisco; Mario Milco D'Elios
Journal:  Int J Mol Sci       Date:  2012-10-19       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.